AR046094A1 - Anticuerpos completamente humanos contra 4-1bb humano - Google Patents
Anticuerpos completamente humanos contra 4-1bb humanoInfo
- Publication number
- AR046094A1 AR046094A1 ARP040103643A ARP040103643A AR046094A1 AR 046094 A1 AR046094 A1 AR 046094A1 AR P040103643 A ARP040103643 A AR P040103643A AR P040103643 A ARP040103643 A AR P040103643A AR 046094 A1 AR046094 A1 AR 046094A1
- Authority
- AR
- Argentina
- Prior art keywords
- human
- chain variable
- variable region
- antibody
- region comprises
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Anticuerpos completamente humanos y porciones de enlace de antígenos de los mismos que se enlazan al 4-1BB humano y que permiten el enlace del 4-1BB humano al ligando 4-1BB humano, así como polinucleótidos que codifican dichos polipéptidos. En un aspecto el anticuerpo es el anticuerpo IgG4. También se suministra un método para el tratamiento del cáncer en un sujeto que comprende administrar una cantidad terapéuticamente efectiva del anticuerpo al sujeto. Reivindicación 1: Un anticuerpo monoclonal o porción de enlace de antígeno del mismo que se enlaza específicamente a 4-1BB, caracterizado porque comprende una región variable de cadena ligera una región variable de cadena pesada, en donde: la región variable de cadena ligera comprende un CDR1, un CDR2 y un CDR3 como se detalla en la figura (4); y la región variable de cadena pesada comprende un CDR1, un CDR2, y un CDR3 como se detalla en la figura (3).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51019303P | 2003-10-10 | 2003-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046094A1 true AR046094A1 (es) | 2005-11-23 |
Family
ID=37426115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103643A AR046094A1 (es) | 2003-10-10 | 2004-10-07 | Anticuerpos completamente humanos contra 4-1bb humano |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN1867585B (es) |
| AR (1) | AR046094A1 (es) |
| PE (1) | PE20050962A1 (es) |
| TW (1) | TWI332844B (es) |
| ZA (1) | ZA200602834B (es) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110357961A (zh) * | 2018-04-10 | 2019-10-22 | 无锡智康弘义生物科技有限公司 | 抗人4-1bb单克隆抗体及其制备方法和用途 |
| CN112010974A (zh) * | 2019-05-30 | 2020-12-01 | 山东博安生物技术有限公司 | 一种特异性结合人4-1bb的抗体及其应用 |
| US11555077B2 (en) | 2017-11-09 | 2023-01-17 | Shanghai Hyamab Biotech Co., Ltd. | 4-1BB antibody and preparation method and use thereof |
| US12054554B2 (en) | 2018-04-10 | 2024-08-06 | Wuxi Biologics (Shanghai) Co., Ltd. | Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101527300B1 (ko) * | 2010-09-09 | 2015-06-09 | 화이자 인코포레이티드 | 4-1ｂｂ 결합 분자 |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| EP3298045A1 (en) * | 2015-05-21 | 2018-03-28 | Alligator Bioscience AB | Novel polypeptides |
| WO2017049452A1 (zh) * | 2015-09-22 | 2017-03-30 | 苏州丁孚靶点生物技术有限公司 | 抗人cd137的完全人抗体及其应用 |
| GB201619648D0 (en) * | 2016-11-21 | 2017-01-04 | Alligator Bioscience Ab | Novel antibodies and uses thereof |
| EP3523332B1 (en) | 2017-01-06 | 2021-12-29 | Eutilex Co., Ltd. | Anti-human 4-1 bb antibodies and use thereof |
| CN116925227A (zh) * | 2017-06-25 | 2023-10-24 | 西雅图免疫公司 | 抗ror1抗体及其制备和使用方法 |
| CA3069438A1 (en) * | 2017-07-11 | 2019-01-17 | Compass Therapeutics Llc | Agonist antibodies that bind human cd137 and uses thereof |
| CN111511762A (zh) * | 2017-08-21 | 2020-08-07 | 天演药业公司 | 抗cd137分子及其用途 |
| WO2019072274A1 (zh) * | 2017-10-12 | 2019-04-18 | 瑞阳(苏州)生物科技有限公司 | 一种激动型4-1bb单克隆抗体 |
| CN109651507B (zh) | 2017-10-12 | 2021-11-26 | 瑞阳(苏州)生物科技有限公司 | 一种激动型4-1bb单克隆抗体 |
| JP2021510533A (ja) * | 2018-01-22 | 2021-04-30 | 江蘇恒瑞医薬股▲ふん▼有限公司 | 抗４−１ｂｂ抗体、その抗原結合フラグメント、およびその医学的使用 |
| WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| CN112867733B (zh) * | 2018-10-19 | 2023-01-06 | 苏州丁孚靶点生物技术有限公司 | 抗cd137抗体及其应用 |
| CN111320691B (zh) * | 2018-12-17 | 2022-04-05 | 程联胜 | 一种抗人4-1bb单克隆抗体及其应用 |
| CN113842456B (zh) * | 2020-06-28 | 2022-07-26 | 上海齐鲁制药研究中心有限公司 | 一种抗人4-1bb的单克隆抗体制剂及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996029348A1 (en) * | 1995-03-23 | 1996-09-26 | Indiana University Foundation | Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases |
| EP0948353A1 (en) * | 1996-10-11 | 1999-10-13 | Bristol-Myers Squibb Company | Methods and compositions for immunomodulation |
-
2004
- 2004-10-07 AR ARP040103643A patent/AR046094A1/es active IP Right Grant
- 2004-10-08 TW TW093130653A patent/TWI332844B/zh not_active IP Right Cessation
- 2004-10-11 PE PE2004000974A patent/PE20050962A1/es active IP Right Grant
- 2004-10-12 CN CN2004800297756A patent/CN1867585B/zh not_active Expired - Fee Related
-
2006
- 2006-04-06 ZA ZA200602834A patent/ZA200602834B/en unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11555077B2 (en) | 2017-11-09 | 2023-01-17 | Shanghai Hyamab Biotech Co., Ltd. | 4-1BB antibody and preparation method and use thereof |
| CN110357961A (zh) * | 2018-04-10 | 2019-10-22 | 无锡智康弘义生物科技有限公司 | 抗人4-1bb单克隆抗体及其制备方法和用途 |
| CN110357961B (zh) * | 2018-04-10 | 2022-08-23 | 无锡智康弘义生物科技有限公司 | 抗人4-1bb单克隆抗体及其制备方法和用途 |
| US12054554B2 (en) | 2018-04-10 | 2024-08-06 | Wuxi Biologics (Shanghai) Co., Ltd. | Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof |
| CN112010974A (zh) * | 2019-05-30 | 2020-12-01 | 山东博安生物技术有限公司 | 一种特异性结合人4-1bb的抗体及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200517124A (en) | 2005-06-01 |
| CN1867585A (zh) | 2006-11-22 |
| TWI332844B (en) | 2010-11-11 |
| CN1867585B (zh) | 2011-02-09 |
| PE20050962A1 (es) | 2005-11-17 |
| ZA200602834B (en) | 2007-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR046094A1 (es) | Anticuerpos completamente humanos contra 4-1bb humano | |
| ES2527961T3 (es) | Anticuerpos monoclonales humanos para CD70 | |
| MXPA06003788A (es) | Anticuerpos completamente humanos contra 4-1bb humano (cd137). | |
| CL2008002923A1 (es) | Anticuerpo monoclonal humano aislado porque se adhiere a mesotelina humana; composicion que comprende dicho anticuerpo; conjugado entre anticuerpo y agente terapeutico; molecula de acido nucleico que codifica el anticuerpo; uso para preparar un medicamento para tratar cancer. | |
| WO2004010947A3 (en) | Humanized antibodies against human 4-1bb | |
| GEP20074222B (en) | Antibodies to cd40 | |
| PE20110797A1 (es) | Anticuerpos anti mn | |
| ES2523194T3 (es) | Anticuerpo monoclonal humano específico para cada tumor | |
| AR050642A1 (es) | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/ calicheamicina | |
| ES2572231T3 (es) | Anticuerpos monoclonales anti-IL-21 humana | |
| RU2011116112A (ru) | Биспецифические анти-egfr/анти-igf-1r антитела | |
| NZ575245A (en) | Targeted binding agents directed to pdgfr-alpha and uses thereof | |
| CL2010000790A1 (es) | Anticuerpos monoclonales que se unen a integrina alfa-nu-beta6 (atcc pta-3898) composicion; hibridoma que lo produce; usos para preparar un medicamento para tratar fibrosis, psoriasis, cancer y otros (div.sol.no. 513-03). | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| EA202092460A1 (ru) | Антитела к ox40 и способы применения | |
| ES2572177T3 (es) | Anticuerpos neutralizantes anti-B7RP1 humanos | |
| UA90457C2 (ru) | Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms | |
| PE20120079A1 (es) | Moleculas de anticuerpos mejoradas | |
| EA201490957A1 (ru) | Лечение гематологических злокачественных заболеваний с помощью анти-cxcr4 антитела | |
| PE20120014A1 (es) | Anticuerpos humanos de alta afinidad contra pcsk9 | |
| PE20121552A1 (es) | Anticuerpos monoclonales anti cea humanizados de afinidad madura | |
| ECSP066432A (es) | Moléculas de enlace terapéuticas | |
| NZ599196A (en) | Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors | |
| PE20061166A1 (es) | Moleculas de anticuerpo que tienen especificidad para la il-17 humana | |
| PE20080214A1 (es) | Moleculas de anticuerpo que se unen a la il-17 humana |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant; registration |